dr perlmutter iv glutathione Randomized, double‐blind, pilot evaluation of intravenous in Parkinson's disease - Hauser - 2009 - Movement Disorders WashU medical school dean, Dr.
Description
Knowing we need the right levels is great, but what about the nutrient absorption issues
N.FeijD
71 Autoimmune diseases
Dyskinesia, a common symptom of Parkinsons disease, is related to glutamatergic neurotransmission, making its modulation a promising therapeutic target
Always check the product instructions, and avoid applying too close to the eyelids unless explicitly stated as safe for that specific area
